SEC Form 4 · accession 0001645470-19-000011
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan Brian Collier
Officer — CEO
Period of report
Feb 12, 2019
Accepted (ET)
Feb 15, 2019 · 9:40 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 12, 2019 | P | 10,000 | $0.0223 | A | 21,354,623 | D | |
| Common Stock | Feb 12, 2019 | P | 2,500 | $0.0223 | A | 21,357,123 | D | |
| Common Stock | Feb 12, 2019 | P | 5,000 | $0.0223 | A | 21,362,123 | D |
Table II — derivative securities
No Table II lines on this filing.